Aytu BioScience(AYTU)
$2.660.00 (0.00%)
AYTU
Aytu BioScience financials statements
$2.66
At close:0.00 (0.00%)
Want to see AYTU full AI Analyst Report?
Aytu BioScience (AYTU) Ratios
1,283 Followers
Aytu BioScience Ratios
AYTU's free cash flow for Q4 2026 was $4.39M. For the 2026 fiscal year, AYTU's free cash flow was decreased by $-12.00K and operating cash flow was $4.41M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.13 | 1.26 | 0.99 | 1.06 | 0.93 |
| Quick Ratio | 1.00 | 1.07 | 0.80 | 0.88 | 0.76 |
| Cash Ratio | 0.48 | 0.49 | 0.32 | 0.33 | 0.30 |
| Solvency Ratio | -0.15 | -0.08 | -0.10 | -0.08 | -1.06 |
| Operating Cash Flow Ratio | 0.06 | -0.03 | -0.02 | -0.07 | -0.45 |
| Short-Term Operating Cash Flow Coverage | 0.40 | -0.18 | -0.28 | -0.59 | -7.56 |
| Net Current Asset Value | $ -7.97M | $ -26.03M | $ -29.25M | $ -25.65M | $ -33.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.18 | 0.14 | 0.22 | 0.13 |
| Debt-to-Equity Ratio | 0.51 | 1.21 | 0.59 | 0.77 | 0.41 |
| Debt-to-Capital Ratio | 0.34 | 0.55 | 0.37 | 0.44 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.21 | 0.36 | 0.28 | 0.35 | 0.24 |
| Financial Leverage Ratio | 2.98 | 6.55 | 4.29 | 3.50 | 3.11 |
| Debt Service Coverage Ratio | -0.84 | -0.35 | -0.08 | -0.24 | -0.18 |
| Interest Coverage Ratio | -4.39 | -2.11 | -0.33 | -3.44 | -0.75 |
| Debt to Market Cap | 0.65 | 1.59 | 1.00 | 5.54 | 0.89 |
| Interest Debt Per Share | 1.62 | 4.24 | 3.83 | 10.60 | 112.71 |
| Net Debt to EBITDA | 0.98 | 1.72 | -2.55 | -2.27 | 0.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 63.95% | 69.04% | 75.26% | 62.04% | 52.02% |
| EBIT Margin | -21.43% | -15.13% | -8.16% | -11.26% | -39.42% |
| EBITDA Margin | -14.60% | -7.03% | 2.16% | -3.05% | -28.92% |
| Operating Profit Margin | -14.44% | -11.79% | -2.44% | -15.89% | -113.69% |
| Pretax Profit Margin | -24.72% | -20.71% | -15.92% | -15.88% | -112.64% |
| Net Profit Margin | -24.76% | -20.43% | -24.31% | -15.88% | -112.53% |
| Continuous Operations Profit Margin | -24.76% | -21.36% | -19.21% | -15.88% | -112.53% |
| Net Income Per EBT | 100.15% | 98.67% | 152.67% | 100.00% | 99.90% |
| EBT Per EBIT | 171.15% | 175.61% | 652.29% | 99.92% | 99.07% |
| Return on Assets (ROA) | -13.57% | -10.92% | -13.33% | -12.37% | -79.04% |
| Return on Equity (ROE) | -40.40% | -71.51% | -57.17% | -43.32% | -245.51% |
| Return on Capital Employed (ROCE) | -16.52% | -12.81% | -2.81% | -24.79% | -150.18% |
| Return on Invested Capital (ROIC) | -14.21% | -10.85% | -2.58% | -22.00% | -142.42% |
| Return on Tangible Assets | -22.41% | -16.54% | -23.86% | -21.62% | -162.38% |
| Earnings Yield | -53.81% | -99.07% | -100.39% | -319.08% | -536.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.53 | 2.13 | 2.77 | 3.71 | 4.45 |
| Payables Turnover | 1.84 | 1.94 | 1.56 | 3.02 | 4.22 |
| Inventory Turnover | 3.03 | 1.80 | 1.33 | 3.40 | 4.28 |
| Fixed Asset Turnover | 46.35 | 41.67 | 42.83 | 27.76 | 15.35 |
| Asset Turnover | 0.55 | 0.53 | 0.55 | 0.78 | 0.70 |
| Working Capital Turnover Ratio | 4.96 | 8.41 | 37.46 | -308.62 | -22.18 |
| Cash Conversion Cycle | 66.61 | 186.10 | 173.08 | 85.07 | 80.89 |
| Days of Sales Outstanding | 144.42 | 171.31 | 131.74 | 98.34 | 81.98 |
| Days of Inventory Outstanding | 120.66 | 203.08 | 274.75 | 107.40 | 85.37 |
| Days of Payables Outstanding | 198.47 | 188.28 | 233.41 | 120.67 | 86.45 |
| Operating Cycle | 265.08 | 374.38 | 406.49 | 205.74 | 167.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.27 | -0.31 | -0.25 | -1.54 | -19.61 |
| Free Cash Flow Per Share | 0.26 | -0.82 | -0.31 | -1.54 | -19.61 |
| Dividend Paid and CapEx Coverage Ratio | 113.14 | -0.60 | -4.22 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 113.14 | -0.60 | -4.22 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.18 | -0.08 | -0.08 | -0.17 | -1.58 |
| Operating Cash Flow to Sales Ratio | 0.06 | -0.03 | -0.02 | -0.05 | -0.30 |
| Free Cash Flow Yield | 12.28% | -37.73% | -10.88% | -95.98% | -142.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.85 | -1.01 | -1.00 | -0.31 | -0.19 |
| Price-to-Sales (P/S) Ratio | 0.46 | 0.21 | 0.24 | 0.05 | 0.21 |
| Price-to-Book (P/B) Ratio | 0.75 | 0.72 | 0.57 | 0.14 | 0.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.14 | -2.65 | -9.19 | -1.04 | -0.70 |
| Price-to-Operating Cash Flow Ratio | 8.07 | -7.07 | -11.37 | -1.04 | -0.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | 0.04 | 0.02 | 0.00 | -0.03 |
| Enterprise Value Multiple | -2.18 | -1.22 | 8.67 | -3.91 | -0.68 |
| Enterprise Value | 18.28M | 5.67M | 12.20M | 12.78M | 19.11M |
| EV to EBITDA | -2.18 | -1.22 | 8.67 | -3.91 | -0.68 |
| EV to Sales | 0.32 | 0.09 | 0.19 | 0.12 | 0.20 |
| EV to Free Cash Flow | 5.62 | -1.10 | -7.10 | -2.49 | -0.66 |
| EV to Operating Cash Flow | 5.57 | -2.93 | -8.79 | -2.49 | -0.66 |
| Tangible Book Value Per Share | -0.50 | -3.70 | -4.47 | -5.87 | -17.91 |
| Shareholders’ Equity Per Share | 2.86 | 3.02 | 5.00 | 11.78 | 30.14 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.03 | -0.21 | 0.00 | 0.00 |
| Revenue Per Share | 4.67 | 10.57 | 11.77 | 32.16 | 65.76 |
| Net Income Per Share | -1.16 | -2.16 | -2.86 | -5.11 | -74.00 |
| Tax Burden | 1.00 | 0.99 | 1.53 | 1.00 | 1.00 |
| Interest Burden | 1.15 | 1.37 | 1.95 | 1.41 | 2.86 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.04 | 0.04 | 0.13 |
| SG&A to Revenue | 0.74 | 0.58 | 0.31 | 0.27 | 0.32 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.04 | 0.06 | 0.05 |
| Income Quality | -0.23 | 0.14 | 0.09 | 0.30 | 0.26 |
Currency in USD

